Gu Ling, Wang Hua, Guo Ya-Lan, Zen Ke
Joint Institute of Virology, Jiangsu Center for Disease Control and Prevention, Nanjing University, Nanjing, Jiangsu 210009, China.
Biochem Biophys Res Commun. 2008 May 16;369(4):1061-4. doi: 10.1016/j.bbrc.2008.02.160. Epub 2008 Mar 13.
Adhesion of Shiga toxin-producing Enterohemorrhagic Escherichia coli (EHEC) O157:H7 to human colonic epithelium is a critical step for infection by this type of bacteria. Here, we demonstrate that adherence of EHEC O157:H7 to cultured human colonic T84 epithelial monolayers can be blocked by heparin and heparan sulfate in a dose-dependent fashion. In doing this, heparin and heparan sulfate also prevent dysfunction of the T84 barrier and disorganization of epithelial tight junction protein ZO-1 caused by EHEC O157:H7. This inhibition by heparin and heparan sulfate seems to result from a block in the binding interactions of bacteria intimin with epithelial beta(1) integrins. This study provides evidence, for the first time, that heparin and heparan sulfate can serve as novel effective blockers in preventing EHEC O157:H7 infection.
产志贺毒素的肠出血性大肠杆菌(EHEC)O157:H7黏附于人类结肠上皮是这类细菌感染的关键步骤。在此,我们证明EHEC O157:H7对培养的人结肠T84上皮单层细胞的黏附可被肝素和硫酸乙酰肝素以剂量依赖方式阻断。在此过程中,肝素和硫酸乙酰肝素还可防止EHEC O157:H7引起的T84屏障功能障碍和上皮紧密连接蛋白ZO-1的紊乱。肝素和硫酸乙酰肝素的这种抑制作用似乎是由于细菌内毒素与上皮β(1)整合素的结合相互作用受阻所致。本研究首次提供证据表明,肝素和硫酸乙酰肝素可作为预防EHEC O157:H7感染的新型有效阻断剂。